Delivery Order SPE2DB24D1006-SPE2DB25FCENZ
Award Date 4/28/25
Potential Completion Date 4/29/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,960.50, is for the delivery of 4,567,237,444 units of the prescription medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of February 12, 2025 and was awarded on February 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp (AmerisourceBergen), a major pharmaceutical distributor. The $1,641.92 contract is for the supply of 4,565,712,501 units of the prescription drug Vyvanse 40 mg capsule. The order has a firm fixed price and an ultimate completion date of September 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,368.57 contract is for the delivery of 4,564,529,038 units of the medication Vyvanse (40 mg capsules) with a performance period through May 8, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,732,659 units of the prescription drug Vyvanse 40 mg capsules. The contract has a ceiling value of $5,456.81 and a completion date of September 9, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,282,842 units of the prescription drug Vyvanse (40 mg capsules) at a ceiling value of $2,289.34. The contract has a firm fixed price pricing type and does not utilize any set-aside designations. It is a child contract associated with a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,162.15, is for the provision of 4,566,357,932 units of the prescription medication Vyvanse 60 mg capsule. The contract is a firm-fixed-price delivery order with a completion date of November 7, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,564,977,305 units of the medication Vyvanse (60 mg capsules) at a ceiling value of $14,850.37. The contract has a period of performance through June 18, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,461.51 firm fixed-price contract is for the delivery of 4,564,027,180 units of the prescription medication Vyvanse 30 mg capsules to support federal healthcare programs. The contract has a completion date of March 21, 2024 and was awarded on March 20, 2024. This order is part of a larger $999,999,999...
- This is a $1,337.70 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to supply 100 units of the medication Vyvanse 60 mg capsules. The contract has a completion date of June 25, 2025 and is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,646.60 firm fixed-price contract is for the delivery of 4,558,621,500 units of the prescription medication Vyvanse 40 mg capsules. The contract has a completion date of September 26, 2022 and was awarded on September 23, 2022. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...